SCHEMBL22618499

SCHEMBL22618499

O=C(O)CCCCCNC(=O)Cc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ ALB P02768 2/20 0.57
▸ ESR1 P03372 1/20 0.56
▸ FOLH1 Q04609 1/20 0.55
▸ CA9 Q16790 10/20 0.54
▸ CA1 P00915 9/20 0.54
▸ CA2 P00918 9/20 0.54
▸ CA12 O43570 6/20 0.54
▸ CA14 Q9ULX7 3/20 0.54
▸ CA7 P43166 3/20 0.54
▸ SLC5A2 P31639 1/20 0.50
▸ MEN1 O00255 1/20 0.49
▸ ALPL P05186 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ ALPI P09923 1/20 0.49
▸ ALPG P10696 1/20 0.49
▸ KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22618495 0.87 ESR1 (0.52) USP2L3MBTL1ALBESR1FOLH1
SCHEMBL22618538 0.87 ESR1 (0.52) USP2L3MBTL1ALBESR1FOLH1
SCHEMBL16295184 0.86 FOLH1 (0.68) USP2L3MBTL1ALBESR1FOLH1
SCHEMBL24596668 0.84 USP2 (0.57) USP2L3MBTL1ALBESR1CA9
Acexamic Acid SCHEMBL30634509 0.83 USP2 (0.55) USP2L3MBTL1ALBESR1FOLH1
SCHEMBL22618502 0.83 ALB (0.52) USP2L3MBTL1ALBESR1FOLH1
SCHEMBL22618487 0.83 ALB (0.52) USP2L3MBTL1ALBESR1FOLH1
SCHEMBL22618551 0.83 ALB (0.52) USP2L3MBTL1ALBESR1FOLH1
SCHEMBL22618511 0.82 ALB (0.52) USP2L3MBTL1ALBESR1FOLH1
SCHEMBL22618554 0.82 ALB (0.52) USP2L3MBTL1ALBESR1FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10822318-B2 Lactone-based probes and methods of use thereof REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2020-11-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10822318-B2 Lactone-based probes and methods of use thereof MRPL21, QPCTL, ARGLU1 USP2 4679/4885L3MBTL1 110/4885ALB 2831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback